These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 6948943

  • 1. Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemia.
    Masera G, Jankovic M, Zurlo MG, Locasciulli A, Rossi MR, Uderzo C, Recchia M.
    J Pediatr; 1982 Jan; 100(1):152-5. PubMed ID: 6948943
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Urate-oxidase as hypouricemic agent in a case of acute tumor lysis syndrome.
    Jankovic M, Zurlo MG, Rossi E, Edefonti A, Cossu MM, Giani M, Masera G.
    Am J Pediatr Hematol Oncol; 1985 Jan; 7(2):202-4. PubMed ID: 3870345
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Uric nephropathy in malignant hemopaties: three cases with conserved diuresis (author's transl)].
    Málaga S, Bayón JM, Matesanz JL, Crespo M.
    An Esp Pediatr; 1976 Jun; 9(4 Suppl):79-87. PubMed ID: 1066072
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of hyperuricemias in hematology using urate oxidase and allopurinol].
    Zittoun R, Dauchy F, Teillaud C, Barthélémy M, Bouchard P.
    Ann Med Interne (Paris); 1976 Jun; 127(6-7):479-82. PubMed ID: 970811
    [No Abstract] [Full Text] [Related]

  • 7. [Letter: Use of urate oxidase and allopurinol as hypouricemic agents in hematology].
    Zittoun R, Dauchy F, Teillaud C, Barthelemy M, Bouchard P.
    Nouv Presse Med; 1976 Jan 10; 5(2):91. PubMed ID: 772604
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.
    Cheuk DK, Chiang AK, Chan GC, Ha SY.
    Cochrane Database Syst Rev; 2014 Aug 14; (8):CD006945. PubMed ID: 25121561
    [Abstract] [Full Text] [Related]

  • 10. Letter: Treatment of malignant haemopathies and urate oxidase.
    Kissel P, Mauuary G, Royer R, Toussain P.
    Lancet; 1975 Jan 25; 1(7900):229. PubMed ID: 47468
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Advances in the management of malignancy-associated hyperuricaemia.
    Mahmoud HH, Leverger G, Patte C, Harvey E, Lascombes F.
    Br J Cancer; 1998 Jun 25; 77 Suppl 4(Suppl 4):18-20. PubMed ID: 9647616
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of urate oxidase (uricozyme) in tumour lysis induced urate nephropathy.
    Leach M, Parsons RM, Reilly JT, Winfield DA.
    Clin Lab Haematol; 1998 Jun 25; 20(3):169-72. PubMed ID: 9681232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.